Different effects of a single and repeated administration of clozapine on phencyclidine-induced hyperlocomotion and glutamate releases in the rat medial prefrontal cortex at short- and long-term withdrawal from this antipsychotic

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 375, Issue 4, 2007, Pages 261-271

  Abekawa, Tomohiro ^a   Ito, Koki ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Clozapine; DOI; Glutamate; mPFC; Phencyclidine

Indexed keywords

CLOZAPINE; GLUTAMIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOWN REGULATION; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; RAT;

AMPHETAMINES; ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; GLUTAMIC ACID; MALE; MOTOR ACTIVITY; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34247877605     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0154-x     Document Type: Article

References (38)

1. 4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats. Psychopharmacology 169:247-256
2. 1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex. Naunyn Schmiedebergs Arch Pharmacol 374:177-193
3. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
4. Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Re Rev 31:302-312
5. 2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro. Neuropsychopharmacology 18:197-209
6. Arvanov VL, Liang X, Schwartz J, Grossman S, Wang RY (1997) Clozapine and Haloperidol modulate N-methyl-D-aspartate- and non-N-methyl-D-aspartate receptor-mediated neurotransmission in rat prefrontal cortical neurons in vitro. J Pharmacol Exp Ther 283:226-234
7. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
8. Berendse HK, Galis DE, Graaf Y, Gronewegen HJ (1992) Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316:314-347
9. 2A receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 91:189-199
10. Comperle A, Olpe HR (2004) Effects of subchronic clozapine treatment on long-term potentiation in rat prefrontal cortex. Eur Neuropsychopharmacol 14:340-346
11. Corbett R, Camacho F, Woods AT (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74
12. 2A receptor expression in discrete brain areas. Pharmacol Biochem Behav 81:750-757
13. Dougherty GG, Ellinwood EH (1983) Influence of gammabutyrolactone on behavior due to dopaminergic drugs. Physiol Behav 30:607-612
14. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
15. Hondo H, Yonezawa Y, Nakahata T, Nakamura K, Hirano M, Uchimura H, Tashiro N (1994) Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study. Brain Res 633:337-342
16. Jardemark KE, Liang X, Arvanov V, Wang RY (2000) Subchronic treatment with either clozapine, olanzapine or haloperidol produces a hyposensitive response of the rat cortical cells to N-methyl-D-asparate. Neuroscience 100:1-9
17. Jentsch JD, Tran A, Taylor JR, Roth RH (1998) Prefrontal cortical involvement in phencyclidine-induced activation of mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacology 138:89-95
18. Jodo E, Suzuki Y, Katayama T, Hoshino K, Takeuchi S, Niwa S, Kayama Y (2005) Activation of medial prefrontal cortex by phencyclidine is mediated via a hippocampo-prefrontal pathway. Cerebral Cortex 15:663-669
19. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003) NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 169:215-233
20. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology 13:139-150
21. Lindroth P, Mopper K (1979) High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Anal Chem 51:1667-1674
22. 2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265:498-508
23. 2A receptors. Eur J Pharmacol 280:R9-R11
24. 2A sites for PCP-induced locomotion in the rat. Eur J Neurosci 11:4419-4432
25. Ninan IPE, Jardemark KE, Wnag RY (2003) Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate-and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex. Synapse 48:66-79
26. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, 3rd edn. Academic Press, USA
27. Riva MA, Tascedda F, Lovati E, Racagni G (1997) Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. Brain Res Mol Brain Res 50:136-142
28. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157-198
29. Saller CF, Salama AI (1993) Seroquel: biochemical profile of a potential atypical antipsychotic. Psychopharmacology 112:285-292
30. Sato M, Chen C-C, Akiyama K, Otsuki S (1993) Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiat 18:429-440
31. Scruggs JL, Schmidt D, Deutch AY (2003) The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137-140
32. Seeman P (2002) Atypical antipsychotics: mechanism of action. Can Psychiatry 47:27-38
33. Sturgeon RD, Fessler RG, Meltzer HY (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur J Pharmacol 59:169-179
34. 2 receptor binding of antipsychotics in vivo. Pharmacol Biochem Behav 49:165-169
35. Suzuki Y, Jodo E, Takeuchi S, Niwa S, Kayama Y (2002) Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience 114:769-779
36. Tarazi FI, Florijn WJ, Creese I (1996) Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128:371-379
37. Yonezawa Y, Kuroki T, Kawahara T, Tashiro N, Uchimura H (1998) Involvement of γ-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. Eur J Pharmacol 341:45-56
38. Zahorodna A, Bobula B, Grzegorzewska M, Tokarski K, Hess G (2004) The influence of repeated administration of clozapine and haloperidol on the effects of the activation of 5-HT(1A), 5-HT(2) and 5-HT(4) receptors in rat frontal cortex. J Physiol Pharmacol 55:371-379